Suppr超能文献

频繁加重型——小儿哮喘的一种新型内型

Frequent exacerbator-a novel endotype of pediatric asthma.

作者信息

Phelan Kieran J, Khurana Hershey Gurjit K

机构信息

Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

出版信息

J Allergy Clin Immunol. 2025 Jul;156(1):61-69. doi: 10.1016/j.jaci.2025.05.006. Epub 2025 May 21.

Abstract

Asthma is a complex and chronic respiratory condition that affects both adult and pediatric populations. Several asthma endotypes have been described; they include endotypes characterized by T2 cell inflammation, response to viral infection, and exposure to air pollution. Recent evidence has revealed a novel endotype of pediatric asthma, termed the frequent exacerbator (FE) endotype, which is characterized by recurrent exacerbations. In this review, we provide an overview of the FE endotype. We review its epidemiology, its definition, and its environmental and clinical associations. We also detail findings from recent molecular characterizations of a pediatric FE endotype, with a specific focus on airway gene expression studies. As asthma exacerbations drive mortality and economic burden associated with disease, understanding the factors leading to frequent exacerbations is an important step in development of novel therapeutics and treatment strategies.

摘要

哮喘是一种复杂的慢性呼吸道疾病,影响成人和儿童群体。已经描述了几种哮喘内型;它们包括以T2细胞炎症、对病毒感染的反应以及接触空气污染为特征的内型。最近的证据揭示了一种新的儿童哮喘内型,称为频繁加重型(FE)内型,其特征是反复加重。在本综述中,我们概述了FE内型。我们回顾了其流行病学、定义以及环境和临床关联。我们还详细介绍了儿童FE内型最近分子特征的研究结果,特别关注气道基因表达研究。由于哮喘加重会导致与疾病相关的死亡率和经济负担,了解导致频繁加重的因素是开发新型治疗方法和治疗策略的重要一步。

相似文献

1
Frequent exacerbator-a novel endotype of pediatric asthma.频繁加重型——小儿哮喘的一种新型内型
J Allergy Clin Immunol. 2025 Jul;156(1):61-69. doi: 10.1016/j.jaci.2025.05.006. Epub 2025 May 21.
2
Antibiotics for exacerbations of asthma.用于哮喘加重期的抗生素
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
3
Vitamin D for the management of asthma.维生素 D 治疗哮喘。
Cochrane Database Syst Rev. 2023 Feb 6;2(2):CD011511. doi: 10.1002/14651858.CD011511.pub3.
4
Anti-IL5 therapies for asthma.用于哮喘的抗白细胞介素-5疗法。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3.
6
Home-based educational interventions for children with asthma.针对哮喘儿童的家庭式教育干预措施。
Cochrane Database Syst Rev. 2025 Feb 6;2(2):CD008469. doi: 10.1002/14651858.CD008469.pub3.
7
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
8
Inhaled magnesium sulfate in the treatment of acute asthma.吸入硫酸镁治疗急性哮喘。
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD003898. doi: 10.1002/14651858.CD003898.pub6.
9
Anti-IL-5 therapies for asthma.哮喘的抗 IL-5 治疗。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD010834. doi: 10.1002/14651858.CD010834.pub4.

本文引用的文献

3
Identification of diurnal rhythmic blood markers in bronchial asthma.支气管哮喘中昼夜节律性血液标志物的鉴定
ERJ Open Res. 2023 Jul 3;9(4). doi: 10.1183/23120541.00161-2023. eCollection 2023 Jul.
7
Mechanisms of Corticosteroid Resistance in Type 17 Asthma.17 型哮喘中皮质类固醇抵抗的机制。
J Immunol. 2022 Nov 15;209(10):1860-1869. doi: 10.4049/jimmunol.2200288.
8
Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk.尿总结合 3-溴酪氨酸、哮喘严重程度和恶化风险。
Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L548-L557. doi: 10.1152/ajplung.00141.2022. Epub 2022 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验